- Article metrics
- Last updated: Tue, 14 Oct 2025 16:00:03 Z
Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression
Access & Citations
-
- 1329
- Article Accesses
-
- 2
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
